Journal
FLY
Volume 16, Issue 1, Pages 275-298Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/19336934.2022.2087484
Keywords
Drosophila; neurodegenerative diseases; reverse translational research
Categories
Funding
- Japan Agency for Medical Research and Developmennt (AMED) [JP22ek019484s]
- Ministry of Education, Culture, Sports, Science and Technology of Japan [18K14835, 18J00367, 21K15619, 19K22592, 21H02837]
- Sasakawa Scientific Research Grant
- GSK Japan Research Grant 2022
Ask authors/readers for more resources
The use of Drosophila in neurodegenerative disease research has contributed to the identification of modifier genes for the pathology and revealed the molecular pathologies involved in human neurological diseases.
The use of Drosophila in neurodegenerative disease research has contributed to the identification of modifier genes for the pathology. The basis for neurodegenerative disease occurrence in Drosophila is the conservation of genes across species and the ability to perform rapid genetic analysis using a compact brain. Genetic findings previously discovered in Drosophila can reveal molecular pathologies involved in human neurological diseases in later years. Disease models using Drosophila began to be generated during the development of genetic engineering. In recent years, results of reverse translational research using Drosophila have been reported. In this review, we discuss research on neurodegenerative diseases; moreover, we introduce various methods for quantifying neurodegeneration in Drosophila.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available